Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Jianxiong Ji; Sonja Dragojevic; Cameron M. Callaghan; Emily J. Smith; Surabhi Talele; Wenjuan Zhang; Margaret A. Connors; Ann C. Mladek; Zeng Hu; Katrina K. Bakken; Paige P. Sarkaria; Brett L. Carlson; Danielle M. Burgenske; Paul A. Decker; Mohammad Abdur Rashid; Mi‐Hyeon Jang; Shiv K. Gupta; Jeanette E. Eckel‐Passow; William F. Elmquist; Jann N. Sarkaria

doi:10.1158/1535-7163.27102355.v1

Abstract

Supplemental Figure 1 shows bar graph of quantification of cells that have >25 gH2AX foci per cell in M15 cell line, after treatment with peposertib and radiation

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ji et al. (2024) studied this question.

synapsesocial.com/papers/68e5778bb6db6435875173ed https://doi.org/10.1158/1535-7163.27102355.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Abstract

Discussion

Cite This Study

Supplementary Figure 1 from Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Abstract

Discussion

Cite This Study

Keep reading

Keep reading